93 related articles for article (PubMed ID: 1836414)
1. [Soluble CD23: cytokine actives on human hematopoietic precursors].
Mossalayi MD; Dalloul AH; Debré P
C R Seances Soc Biol Fil; 1991; 185(4):198-205. PubMed ID: 1836414
[TBL] [Abstract][Full Text] [Related]
2. Effect of CD23 on purified human hematopoietic cells.
Mossalayi D; Dalloul A; Arock M; Debre P
Bone Marrow Transplant; 1992; 9 Suppl 1():50-3. PubMed ID: 1387018
[TBL] [Abstract][Full Text] [Related]
3. The small subpopulation of T cell marker+/TdT+ cells in the human bone marrow may represent prothymocytes.
van Dongen JJ; Hooijkaas H; Comans-Bitter WM; Hählen K; van Zanen GE
Adv Exp Med Biol; 1985; 186():889-99. PubMed ID: 3931434
[No Abstract] [Full Text] [Related]
4. Inhibition of interleukin-3-dependent growth of CD34+ acute myelogenous leukemia cells by recombinant soluble CD23.
Mossalayi MD; Merle-Beral H; Dalloul AH; Arock M; Michel A; Hofstetter H; Debre P
Ann N Y Acad Sci; 1991; 628():362-7. PubMed ID: 1712558
[No Abstract] [Full Text] [Related]
5. Thymic epithelial cell-derived supernatants sustain the maturation of human prothymocytes: involvement of interleukin 1 and CD23.
Dalloul AH; Fourcade C; Debré P; Mossalayi MD
Eur J Immunol; 1991 Oct; 21(10):2633-6. PubMed ID: 1717288
[TBL] [Abstract][Full Text] [Related]
6. Proliferation of early human myeloid precursors induced by interleukin-1 and recombinant soluble CD23.
Mossalayi MD; Arock M; Bertho JM; Blanc C; Dalloul AH; Hofstetter H; Sarfati M; Delespesse G; Debré P
Blood; 1990 May; 75(10):1924-7. PubMed ID: 2140059
[TBL] [Abstract][Full Text] [Related]
7. [Phenotypic and functional characterization of human prothymocytes].
Mossalayi MD; Dalloul AH; Blanc C; Arock M; Debré P
C R Seances Soc Biol Fil; 1994; 188(1):31-8. PubMed ID: 7994627
[TBL] [Abstract][Full Text] [Related]
8. [Proliferation of blast cells of the bone marrow in adults with acute leukemia].
Averbakh AV
Lab Delo; 1976; (3):137-40. PubMed ID: 58114
[No Abstract] [Full Text] [Related]
9. Cytokine effects of CD23 are mediated by an epitope distinct from the IgE binding site.
Mossalayi MD; Arock M; Delespesse G; Hofstetter H; Bettler B; Dalloul AH; Kilchherr E; Quaaz F; Debré P; Sarfati M
EMBO J; 1992 Dec; 11(12):4323-8. PubMed ID: 1385115
[TBL] [Abstract][Full Text] [Related]
10. Committed precursors of B and T lymphocytes in chick embryo bursa of Fabricius, thymus, and bone marrow.
Brand A; Galton J; Gilmour DG
Eur J Immunol; 1983 Jun; 13(6):449-55. PubMed ID: 6190659
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of acute leukemia by quantitative observation of leukemic cells and normal hematopoietic cells in the bone marrow (author's transl)].
Oshima T
Nihon Ketsueki Gakkai Zasshi; 1974 Oct; 37(5):773-4. PubMed ID: 4533931
[No Abstract] [Full Text] [Related]
12. Synergistic effect of interleukin 1 and soluble CD23 on the growth of human CD4+ bone marrow-derived T cells.
Bertho JM; Fourcade C; Dalloul AH; Debré P; Mossalayi MD
Eur J Immunol; 1991 Apr; 21(4):1073-6. PubMed ID: 1673432
[TBL] [Abstract][Full Text] [Related]
13. [Proliferative activity of leukemic cell population of the bone marrow and peripheral blood in acute leukemia].
Averbakh AV; Vladimirskaia EB; Solov'eva EA
Lab Delo; 1978; (2):67-70. PubMed ID: 76004
[No Abstract] [Full Text] [Related]
14. Lymphocytes. 2. Differentiation. Differentiation of lymphoid precursor cells.
Janossy G; Pizzolo G
J Clin Pathol Suppl (R Coll Pathol); 1979; 13():48-58. PubMed ID: 391826
[No Abstract] [Full Text] [Related]
15. The role of CD23 on early human hematopoietic precursors.
Mossalayi MD; Dalloul AH; Fourcade C; Arock M; Merle-Beral H; Hofstetter H; Debré P
Monogr Allergy; 1991; 29():178-85. PubMed ID: 1836535
[No Abstract] [Full Text] [Related]
16. Effect of retinoic acid on the clonal growth of childhood myeloid and lymphoid leukemias: a pediatric oncology group study.
Findley HW; Steuber CP; Ruymann FB; Culbert S; Ragab AH
Exp Hematol; 1984 Nov; 12(10):768-73. PubMed ID: 6334611
[TBL] [Abstract][Full Text] [Related]
17. T-cell acute lymphoblastic leukemia relapsing as acute myelomonocytic leukemia and terminating possibly as chronic myelocytic leukemia.
Shimizu J; Hamashima Y; Tsuda H; Akiyama Y; Mikawa H; Ikehara S
Am J Hematol; 1987 Feb; 24(2):199-205. PubMed ID: 3492913
[TBL] [Abstract][Full Text] [Related]
18. T cell differentiation/maturation of CD34+ stem cells from HIV-seropositive hemophiliacs in cultured thymic epithelial fragments.
Ruiz M; Roodman ST; Bouhasin JD; Knutsen AP
Stem Cells; 1996 Jan; 14(1):132-45. PubMed ID: 8820959
[TBL] [Abstract][Full Text] [Related]
19. The cytoplasmic expression of CD3 antigens in normal and malignant cells of the T lymphoid lineage.
Campana D; Thompson JS; Amlot P; Brown S; Janossy G
J Immunol; 1987 Jan; 138(2):648-55. PubMed ID: 3098852
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of colony-forming cells from bone marrow of leukemic patients by 3-oxauracil.
Reiner P; Mardiak J; Reinerová M; Ujházy V
Neoplasma; 1981; 28(5):533-9. PubMed ID: 6947140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
